DNA

DNA Other Income/Expenses (Net)

-$4.79MTTM · USD

Period ending:

DNA FY Other Income/Expenses (Net)USD
DNA FY Other Income/Expenses (Net)2019-12-31: -$48.24M2020-12-31: $12.19M2021-12-31: -$9.66M2022-12-31: $87.55M2023-12-31: -$28.53M2024-12-31: $12.25M2025-12-31: $1.68M$87.55M-$48.24M
2019-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

DNA other income/expenses (net) history

Net other income and expenses outside core operations. The available annual fiscal periods series contains 7 observations from Dec 31, 2019 to Dec 31, 2025.

Ginkgo Bioworks Holdings Inc Class Other Income/Expenses (Net) — Annual fiscal periods (USD)
Period endingOther Income/Expenses (Net) (USD)
1,678,000
12,249,000
-28,534,000
87,553,000
-9,655,000
12,193,000
-48,237,000

Compare other income/expenses (net)

All DNA financial metrics · DNA stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.